.jpg){kind=tracking}
Statement from FDA Commissioner Scott Gottlieb, M.D., and Director of FDA’s Center for Biologics Evaluation and Research Peter Marks, M.D., Ph.D., on efforts to promote and foster blood pathogen reduction technologies
Reports of influenza cases inched downward during the week ending March 9, but they remain relatively high due in part to the spread of the H3N2 virus, the Centers for Disease Control and Prevention reported.
.jpg){kind=tracking}
The U.S. Food and Drug Administration issued warning letters to two breast implant manufacturers for failure to comply with their requirements, under their premarket approval orders, to conduct post-approval studies to assess the long-term safety and risks of their silicone gel-filled breast implants.